Orexigen: Anti-Obesity Drug Attempting to Enter Multiple Markets
Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.
Orexigen Therapeutics is a biopharmaceutical company that focuses its attention on the treatment of one of the most common diseases in existence today, obesity.
A new study from the Scripps Research Institute has shown that the molecular mechanism that causes drug addiction is the same mechanism that drives people to compulsively eat.
GI Dynamics has received European CE mark approval to commercialize a non-surgical device for the management of obesity and Type 2 diabetes.
The race for an anti-obesity drug intensified Wednesday with the latest mid-stage trial data from Orexigen Therapeutics.
Copyright © 2024 | WordPress Theme by MH Themes